(Q38926338)

7 September 2017

title

Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity (English)

1 reference

7 September 2017

J Y Kim

1

1 reference

7 September 2017

S-C Lim

2

1 reference

7 September 2017

G Kim

3

1 reference

7 September 2017

H J Yun

4

1 reference

7 September 2017

S-G Ahn

5

1 reference

7 September 2017

H S Choi

6

1 reference

7 September 2017

language of work or name

English

0 references

publication date

22 December 2014

1 reference

7 September 2017

1 reference

7 September 2017

volume

34

1 reference

7 September 2017

issue

38

1 reference

7 September 2017

page(s)

4928-4938

1 reference

Interleukin 33 as a mechanically responsive cytokine secreted by living cells

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

A cytokine-mediated link between innate immunity, inflammation, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

AP-1: a double-edged sword in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

The regulation of AP-1 activity by mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Cancer. Respect thy neighbor!

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

The cytokine interleukin-33 mediates anaphylactic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

TRAF6 is a signal transducer for interleukin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

TRAF6 is a critical signal transducer in IL-33 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Coordinating ERK/MAPK signalling through scaffolds and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Cot, a novel kinase of histone H3, induces cellular transformation through up-regulation of c-fos transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

5'-Nitro-indirubinoxime inhibits epidermal growth factor- and phorbol ester-induced AP-1 activity and cell transformation through inhibition of phosphorylation of Pin1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Autocrine-mediated activation of STAT3 correlates with cell proliferation in breast carcinoma lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Molecular cloning of the murine ST2 gene. Characterization and chromosomal mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.418

Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis

31 March 2020

1 reference

12 December 2020

Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia

1 reference

12 December 2020

EGFR dependent expression of STAT3 (but not STAT1) in breast cancer

1 reference

12 December 2020

Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor

1 reference

12 December 2020

Identifiers

DOI

10.1038/ONC.2014.418

1 reference

Dimensions Publication ID

7 September 2017

1039086502

0 references

1 reference